Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 550 of 885 entries
View as:

A Pharmacokinetic Study of Ustekinumab in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02968108 Org: User:
Start: 01/18/17 End: 03/18/22 Due: 03/18/23

Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-64565111 in Type 2 Diabetes Mellitus (T2DM)

Phase: N/A Priority: Normal
NCT ID: NCT02862431 Org: User:
Start: 07/12/16 End: 12/05/16 Due: 12/05/17

A Study to Assess the Effect of Ticlopidine on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03298906 Org: User:
Start: 09/26/17 End: 11/27/17 Due: 11/27/18

A Study of Severe Uterine Bleeding Following Exposure to Direct Oral Anticoagulants

Phase: N/A Priority: Normal
NCT ID: NCT04394234 Org: User:
Start: 05/15/20 End: 06/01/20 Due: 06/01/21

A Study of JNJ-64140284 Solid Dose Formulations in Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT04033458 Org: User:
Start: 07/29/19 End: 08/01/19 Due: 08/01/20

A Study of 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) and High-dose Quadrivalent Influenza Vaccine, With and Without Co-administration, in Adults Aged 65 Years or Older

Phase: N/A Priority: Normal
NCT ID: NCT06134804 Org: User:
Start: 10/24/23 End: 07/26/24 Due: 07/26/25

A Study of Oral Seltorexant as an add-on Medication to an Antidepressant on On-road Driving Performance in Participants With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT04451187 Org: User:
Start: 07/16/20 End: 03/16/23 Due: 03/16/24

A Study to Evaluate the Effect of Renal Impairment on JNJ-42847922 in Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT04616677 Org: User:
Start: 03/31/21 End: 10/18/22 Due: 10/18/23

A Thorough QT Study of Aticaprant (JNJ-67953964) in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT05387759 Org: User:
Start: 05/30/22 End: 10/04/22 Due: 10/04/23

Characterization of T-Cell Response in Participants Previously Treated With JNJ-54861911 (Atabecestat)

Phase: N/A Priority: Normal
NCT ID: NCT03587376 Org: User:
Start: 05/30/18 End: 08/23/18 Due: 08/23/19

The Effect of Minocycline on Relapse After Successful Intravenous Ketamine/Minocycline-induced Symptoms Response in Subjects With Depression

Phase: N/A Priority: Normal
NCT ID: NCT01809340 Org: User:
Start: 06/30/13 End: 07/31/14 Due: 07/31/15

A Study of New Transdermal Contraceptive Patch at End of Shelf Life and Currently Marketed EVRA at the Beginning of Shelf Life in Healthy Women

Phase: N/A Priority: Normal
NCT ID: NCT04017195 Org: User:
Start: 07/12/19 End: 12/13/19 Due: 12/13/20

Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Healthy Han Chinese, Korean, Japanese, and Caucasian Participants and the Effects of Rifampin on the Pharmacokinetics of Intranasally Administered Esketamine

Phase: N/A Priority: Normal
NCT ID: NCT02846519 Org: User:
Start: 02/26/16 End: 05/28/16 Due: 05/28/17

Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03239561 Org: User:
Start: 09/06/17 End: 04/30/18 Due: 04/30/19

A Study to Investigate the Antidepressant Mechanism-of-action of JNJ-42847922 in Participants With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT03374475 Org: User:
Start: 01/05/18 End: 04/29/19 Due: 04/29/20

A Study to Assess the Effect of Ritonavir on the Single-Dose Pharmacokinetics of JNJ-61393215 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03593954 Org: User:
Start: 07/31/18 End: 09/19/18 Due: 09/19/19

Crossover Study to Evaluate the Abuse Potential of Intranasal Esketamine Compared to Racemic Intravenous Ketamine in Nondependent, Recreational Drug Users

Phase: N/A Priority: Normal
NCT ID: NCT02682225 Org: User:
Start: 03/25/16 End: 01/09/17 Due: 01/09/18

A Study to Evaluate the Effects of a Single-Dose and Repeat-Administration of Intranasal Esketamine on On-Road Driving in Participants With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT02919579 Org: User:
Start: 10/07/16 End: 06/29/18 Due: 06/29/19

A Single and Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of JNJ-42165279 in Healthy Japanese Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT03564379 Org: User:
Start: 06/12/18 End: 08/13/18 Due: 08/13/19

A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-55375515 in Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT03405441 Org: User:
Start: 01/02/18 End: 09/04/18 Due: 09/04/19

A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment

Phase: N/A Priority: Normal
NCT ID: NCT05455320 Org: User:
Start: 10/13/22 End: 09/30/29 Due: 09/30/30

A Study of JNJ-42847922 (Seltorexant) in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05236868 Org: User:
Start: 02/03/22 End: 03/01/22 Due: 03/01/23

A Study to Evaluate the Effects of Single-dose Seltorexant on Electrocardiogram Intervals in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT03494907 Org: User:
Start: 04/09/18 End: 08/13/18 Due: 08/13/19

A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPC

Phase: N/A Priority: Normal
NCT ID: NCT05884398 Org: User:
Start: 08/31/23 End: 03/21/27 Due: 03/21/28

A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04951154 Org: User:
Start: 03/28/22 End: 05/12/23 Due: 05/12/24